Keyphrases
Methylenetetrahydrofolate Reductase (MTHFR)
100%
Prothrombin
100%
Behet's Disease
100%
Thrombogenic
100%
Vascular Behçet Disease
100%
Arab
75%
Jewish Patients
50%
Israeli
25%
Jewish
25%
Homozygote
25%
Non-associated
25%
Clinical Evaluation
25%
Non-carriers
25%
Thrombosis
25%
Deep Vein Thrombosis
25%
Sporadic Cases
25%
Arterial Occlusion
25%
Thrombotic Events
25%
Genetic Evaluation
25%
Gene Defects
25%
Thrombosis Risk
25%
Familial Cases
25%
Vasculitis
25%
Thrombophlebitis
25%
Factor V Leiden mutation
25%
Disease Manifestations
25%
Defect Factor
25%
Arterial Aneurysm
25%
Leiden
25%
Prothrombin 20210A
25%
Thrombophilic Genes
25%
Medicine and Dentistry
Disease
100%
Methylenetetrahydrofolate Reductase
100%
Prothrombin
100%
Factor V
100%
Thrombosis
40%
Clinical Trial
20%
Allele
20%
Deep Vein Thrombosis
20%
Artery Occlusion
20%
Vasculitis
20%
Aneurysm
20%
Homozygote
20%
Thrombophlebitis
20%
Factor V Leiden
20%
Genetic Evaluation
20%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Prothrombin
100%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
100%
Blood Clotting Factor 5
100%
Thrombosis
40%
Deep Vein Thrombosis
20%
Artery Occlusion
20%
Vasculitis
20%
Aneurysm
20%
Thrombophlebitis
20%
Blood Clotting Factor 5 Leiden
20%
Biochemistry, Genetics and Molecular Biology
Methylenetetrahydrofolate Reductase
100%
Factor V
100%
Prothrombin
100%
Allele
33%
Clinical Trial
33%
Factor V Leiden
33%
Homozygote
33%
Genetic Evaluation
33%
Deep Vein Thrombosis
33%